Hauck & Aufhaeuser Analysts Give Gerresheimer (GXI) a €55.00 Price Target

Gerresheimer (ETR:GXI) has been given a €55.00 ($67.90) target price by research analysts at Hauck & Aufhaeuser in a research report issued to clients and investors on Tuesday. The firm presently has a “sell” rating on the stock. Hauck & Aufhaeuser’s price target would indicate a potential downside of 14.40% from the stock’s previous close.

Other analysts have also issued reports about the stock. Commerzbank set a €77.00 ($95.06) target price on shares of Gerresheimer and gave the company a “buy” rating in a research report on Monday. JPMorgan Chase & Co. set a €87.70 ($108.27) target price on shares of Gerresheimer and gave the company a “buy” rating in a research report on Tuesday. Kepler Capital Markets set a €65.00 ($80.25) target price on shares of Gerresheimer and gave the company a “sell” rating in a research report on Tuesday. Goldman Sachs Group set a €68.00 ($83.95) target price on shares of Gerresheimer and gave the company a “neutral” rating in a research report on Thursday, January 25th. Finally, Independent Research set a €74.00 ($91.36) target price on shares of Gerresheimer and gave the company a “neutral” rating in a research report on Thursday, January 25th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of €71.61 ($88.41).

Shares of Gerresheimer (ETR:GXI) opened at €64.25 ($79.32) on Tuesday. Gerresheimer has a 12-month low of €59.97 ($74.04) and a 12-month high of €78.25 ($96.60). The firm has a market cap of $2,010.00 and a PE ratio of 45.57.

TRADEMARK VIOLATION WARNING: This report was first posted by Stock Observer and is the property of of Stock Observer. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://www.thestockobserver.com/2018/02/06/hauck-55-00-price-target.html.

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply